HUTCHMED (China) Future Growth
Future criteria checks 0/6
Key information
18.0%
Earnings growth rate
17.1%
EPS growth rate
Pharmaceuticals earnings growth | 14.2% |
Revenue growth rate | 11.3% |
Future return on equity | 12.4% |
Analyst coverage | Good |
Last updated | 10 Jun 2024 |
Recent future growth updates
Recent updates
We Think HUTCHMED (China) (LON:HCM) Can Manage Its Debt With Ease
Apr 04HUTCHMED (China) Limited's (LON:HCM) P/S Is Still On The Mark Following 31% Share Price Bounce
Mar 14The HUTCHMED (China) Limited (LON:HCM) Analysts Have Been Trimming Their Sales Forecasts
Mar 01Market Cool On HUTCHMED (China) Limited's (LON:HCM) Revenues
Dec 18HUTCHMED (China) (LON:HCM) Is Using Debt Safely
Nov 23Does HUTCHMED (China) (LON:HCM) Have A Healthy Balance Sheet?
Aug 24Is HUTCHMED (China) (LON:HCM) A Risky Investment?
May 10With HUTCHMED (China) Limited (LON:HCM) It Looks Like You'll Get What You Pay For
Apr 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,043 | 98 | 44 | 71 | 14 |
12/31/2025 | 846 | 1 | -44 | -16 | 21 |
12/31/2024 | 689 | -106 | -182 | -109 | 20 |
12/31/2023 | 838 | 101 | 187 | 219 | N/A |
9/30/2023 | 798 | 36 | 95 | 133 | N/A |
6/30/2023 | 757 | -29 | 2 | 48 | N/A |
3/31/2023 | 592 | -195 | -151 | -110 | N/A |
12/31/2022 | 426 | -361 | -305 | -269 | N/A |
9/30/2022 | 414 | -308 | -276 | -246 | N/A |
6/30/2022 | 401 | -255 | -246 | -223 | N/A |
3/31/2022 | 376 | -235 | -245 | -227 | N/A |
12/31/2021 | 356 | -195 | -221 | -204 | N/A |
9/30/2021 | 317 | -187 | -169 | -155 | N/A |
6/30/2021 | 279 | -178 | -118 | -105 | N/A |
3/31/2021 | 258 | -151 | -95 | -83 | N/A |
12/31/2020 | 228 | -126 | -70 | -62 | N/A |
9/30/2020 | 221 | -117 | -72 | -63 | N/A |
6/30/2020 | 209 | -110 | -88 | -79 | N/A |
3/31/2020 | 204 | -102 | -63 | -54 | N/A |
12/31/2019 | 205 | -106 | -89 | -81 | N/A |
9/30/2019 | 205 | -93 | -86 | -77 | N/A |
6/30/2019 | 214 | -87 | -52 | -44 | N/A |
3/31/2019 | 214 | -83 | -37 | -31 | N/A |
12/31/2018 | 214 | -75 | -39 | -33 | N/A |
9/30/2018 | 218 | -72 | -38 | -33 | N/A |
6/30/2018 | 217 | -61 | -51 | -47 | N/A |
3/31/2018 | 230 | -39 | -54 | -49 | N/A |
12/31/2017 | 241 | -27 | -14 | -9 | N/A |
9/30/2017 | 240 | -7 | N/A | -4 | N/A |
6/30/2017 | 238 | 13 | N/A | 1 | N/A |
3/31/2017 | 227 | 12 | N/A | -4 | N/A |
12/31/2016 | 216 | 12 | N/A | -10 | N/A |
9/30/2016 | 200 | 38 | N/A | 2 | N/A |
6/30/2016 | 200 | -8 | N/A | -1 | N/A |
3/31/2016 | 189 | -22 | N/A | -5 | N/A |
12/31/2015 | 178 | -35 | N/A | -9 | N/A |
9/30/2015 | 168 | -80 | N/A | -11 | N/A |
6/30/2015 | 139 | -66 | N/A | -6 | N/A |
3/31/2015 | 113 | -50 | N/A | 1 | N/A |
12/31/2014 | 87 | -35 | N/A | 8 | N/A |
9/30/2014 | 72 | -20 | N/A | 11 | N/A |
6/30/2014 | 59 | 7 | N/A | 21 | N/A |
3/31/2014 | 52 | 8 | N/A | 13 | N/A |
12/31/2013 | 37 | 26 | N/A | 5 | N/A |
9/30/2013 | 38 | 10 | N/A | 0 | N/A |
6/30/2013 | 30 | 13 | N/A | -5 | N/A |